Simulations Plus (SLP) Announces Collaboration Agreement with Top-5 Pharma Company

June 13, 2012 8:01 AM EDT Send to a Friend
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to extend and enhance its oral cavity dosing model within its industry gold standard GastroPlus™ simulation software program.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Add Your Comment